Randomized phase II study of S-1 and concurrent radiotherapy with versus without induction chemotherapy for locally advanced pancreatic cancer. (JCOG1106)
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 06 Jun 2017
At a glance
- Drugs Gemcitabine (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 06 Jun 2017 Results of an exploratory subgroup analysis (n=100) assessing the effect of inflammatory and nutritional status on induction chemotherapy followed by chemoradiotherapy for locally advanced pancreatic cancer, presented at the 53rd Annual Meeting of the American Society of Clinical Oncology.
- 20 Sep 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 05 Dec 2011 New trial record